Founder & Executive Chairperson at Biocon
Generics are copies of small, chemically synthesized molecules like aspirin, which have simple structures. Biosimilars are copies of large, complex proteins produced by living cells, like monoclonal antibodies. Because proteins fold into complex shapes, copying them requires high-level biotechnology.
This answer is part of a full interview with Kiran Mazumdar-Shaw, Founder & Executive Chairperson at Biocon.
Found this insight valuable? Share it with your network to help others learn from Kiran Mazumdar-Shaw's experience.
Use this answer in your research, article, or academic work
